Additionally, consistent with previously published data (46), chr8 gain and high EIF4EBP1 expression are associated with unfavorable patient survival in several other cancer entities (chr8 gain in 4 and high EIF4EBP1 expression in 14 of 32 identified entities) (Supplemental Table 4). This evidence concerns the gene EIF4EBP1 and cancer.